The transcatheter embolization and occlusion devices market size is expected to see rapid growth in the next few years. It will grow to $7.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing research and development activities, an increase in the healthcare sector, growing minimally invasive techniques, an increase in the older population, and an increase in workshops and awareness among people. Major trends in the forecast period include technological advancements, advancements in imaging, integration of artificial intelligence and machine learning, continuous improvements in device design, and advancement in delivery systems.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report
Scope Of Transcatheter Embolization And Occlusion Devices Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Transcatheter Embolization And Occlusion Devices Market Overview
Market Drivers –
The growing demand for minimally invasive techniques is expected to propel the growth of the transcatheter embolization and occlusion devices market going forward. Minimally invasive surgeries refer to surgical approaches that use small incisions or natural body openings to access and treat internal structures, organs, or tissues to minimize trauma to the patient’s body. Transcatheter embolization and occlusion devices are integral to minimally invasive techniques, offering numerous benefits such as reduced invasiveness, shorter recovery times, localized treatment, less pain, lower risk of complications, and the potential for outpatient procedures. For instance, in January 2023, according to Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive care products, in 2022, approximately 1,875,000 surgical procedures were performed with vinci surgical systems, an increase of roughly 18% compared with approximately 1,594,000 surgical procedures performed in 2021. Therefore, the growing demand for minimally invasive techniques drives the growth of the transcatheter embolization and occlusion devices market.
Market Trends –
Major companies operating in the transcatheter embolization and occlusion devices market are developing technologically advanced products with functionality, such as multi-catheter compatibility, to serve customers with advanced features better and gain a competitive edge in the market. Multi-catheter compatibility is a feature that can be used with various types of catheters during interventional procedures to offer healthcare providers greater versatility and efficiency in performing transcatheter embolization and occlusion procedures. For instance, in April 2022, Boston Scientific, a US-based medical products company, received FDA clearance for its EMBOLD Fibered Detachable Coil, designed for embolization procedures in the peripheral vasculature. This device is part of the interventional oncology portfolio. It aims to obstruct or reduce blood flow in targeted vessels, addressing conditions such as hemorrhaging, aneurysms, tumor reduction, and venous abnormalities. It features multi-catheter compatibility and a nitinol delivery system to prevent kinks. The coil streamlines procedures reduces potential complications and enhances efficiency.
The transcatheter embolization and occlusion devices market covered in this report is segmented –
1) By Type: Coil, Non-Coil
2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users
Get an inside scoop of the transcatheter embolization and occlusion devices market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15944&type=smp
Regional Insights –
North America was the largest region in the transcatheter embolization and occlusion devices market in 2023. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the transcatheter embolization and occlusion devices market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., AtriCure Inc, Nordion Inc., Sirtex Medical Limited, Cordis Corporation, OpSens Inc., pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc.
Table of Contents
1. Executive Summary
2. Transcatheter Embolization And Occlusion Devices Market Report Structure
3. Transcatheter Embolization And Occlusion Devices Market Trends And Strategies
4. Transcatheter Embolization And Occlusion Devices Market – Macro Economic Scenario
5. Transcatheter Embolization And Occlusion Devices Market Size And Growth
…..
27. Transcatheter Embolization And Occlusion Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Related Topics:
https://goodprnews.com/influenza-treatment-market-size/
https://goodprnews.com/lipid-regulators-market-size/
https://goodprnews.com/multi-cancer-early-detection-market-size/
https://topprnews.com/influenza-treatment-market-share/
https://topprnews.com/lipid-regulators-market-share/
https://topprnews.com/multi-cancer-early-detection-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
